EVELYN SOMMARIVA: Open Payments
NPI 1619167657 · CANTON, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,811 in 73 payments from 18 companies in 2025. Trend: 2023 $1,346 · 2024 $2,092 · 2025 $1,811
Food & beverage: $1,672Education: $139
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 18 | $407 |
| Novartis Pharmaceuticals Corporation | 10 | $220 |
| Incyte Corporation | 10 | $204 |
| Regeneron Healthcare Solutions, Inc. | 5 | $178 |
| Lilly USA, LLC | 3 | $148 |
| LEO Pharma Inc. | 3 | $147 |
| GENZYME CORPORATION | 6 | $146 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $108 |
| UCB, Inc. | 2 | $48 |
| Organon LLC | 2 | $43 |
Products named: TREMFYA, DUPIXENT, OPZELURA, COSENTYX, ANZUPGO, ILUMYA, EBGLYSS, Rhapsido.
Industry payments across MI — which companies pay providers there.
